Eczema is one of the most common reasons for consultation in older people. Many differential diagnoses must be eliminated, including scabies, bullous pemphigoid, and mycosis fungoides. Contact dermatitis may also be considered and the chemical(s) in question may vary according to the comorbidities involved, in particular, depending on whether or not the patient has a leg ulcer. Drug-induced eczematous eruptions can occur in elderly people, mainly with antihypertensive drugs (calcium inhibitors, diuretics, etc.). Recently, de novo atopic dermatitis has been described in elderly subjects, and the role of pollution has been evoked for these eczemas. Management of eczema in the elderly is challenging, and emollients and dermocorticosteroids are helpful. However, local corticosteroids may have some adverse effects in this vulnerable population, such as skin atrophy, diabetes and hypertension. Phototherapy, when possible, and low-dose methotrexate in particular may be interesting treatment options.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Demographic review 2018. INSEE. Statistics. Available at: www.insee.fr/fr/information/3697254 (accessed 18 May 2020).
United Nations. World population ageing. Available at: www.un.org/en/sections/issues-depth/ageing/ (accessed 18 May 2020).
Katoh N, Tennstedt D, Abellan Van Kan G, et al. Gerontodermatology: the fragility of the epidermis in older adults. J Eur Acad Dermatol 2018; 3: 1–20.
Thivolet J, Nicolas JF. Skin ageing and immune competence. Br J Dermatol 1990; 122: 13–20.
Caruso C, Buffa S, Candore G, et al. Mechanisms of immunose-nescence. Immun Ageing 2009; 6: 10.
Beauregard S, Gilchrest BA. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol 1987; 123: 1638–43.
Kimura N, Nakagami G, Takehara K, et al. Prevalence of atseatosis and asteatotic eczema among elderly residents in facilities covered by long-term care insurance. J Dermatol 2013;40:770–1.
Heng YK, Lim YL. Cutaneous adverse drug reactions in the elderly. Curr Opin Allergy Clin Immunol 2015; 15: 300–7.
Yalçin B, Tarner E, Toy GG, Oztas P, Hayran M, Alli N. The prevalence of skin diseaes in the elderly: analysis of 4099 geriatric patients. Int J Dermtol 2006;45: 672–6.
Reszke R, Dorota P, Walasek A, Machaj Z, Reich A. Skin disorders in elderly subjects. Int J Dermatol 2015; 54: 332–8.
Cassel JA, Middleton J, Nalabanda A, et al. Scabies outbreaks in ten care homes for elderly people: a prospective study of clincal features, epidemiology and treatment outcomes. Lancet Infect Dis 2018;18:894–902.
Bastuji-Garin S, Joly P, Lemordant P, et al. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. J Invest Dermatol 2011;131:637–43.
Chou PS, Chou TC, Chang CH, Yu S, Lee CH. Chronic eczematous dermatitis in patients with neurodegenerative diseases may be an early marker of bullous pemphigoid. Medical hypotheses 2017; 103:86–9.
Honig BJ, Horn TD, Macghee A, et al. Widespread eczematous dermatitis with erythematous facial plaques. Alopecia mucinosa (follicular mucinosis)] with possible mycosis fongoides. Arch Dermatol 1991; 127: 1397.
Nosbaum A, Vocanson M, Rozières A, Hennino A, Nicolas JF. Allergic and irritant contact dermatitis. Eur J Dermatol 2009; 19: 325–32.
Balato A, Balato N, Di Costanzo L, Ayala F. Contact sensitization in the elderly. Clin Dermatol 2011; 29: 24–30.
Uter W, Geier J, Pfahlberg A, Effendy I. The spectrum of contact allergy in elderly patients with and without lower legs dermatitis. Dermatology 2002; 204: 266–72.
Panasoff J. Widespread eczema in an elderly patient. Contact Dermatitis 2018; 78: 287–306.
Piaserico S, Larese F, Recchia GP, et al. Allergic contact sensitivity in elderly patients. Aging Clin Exp Res 2004; 16: 221–5.
Gupta G, Dawn G, Forsyth A. The trend of allergic contact dermatitis in the elderly population over 15-year period. Contact dermatitis 1999;41:48.
Schäfer I, Hansen H, Schön G, et al. The influence of age, gender and socioeconomic status on multimorbidity patterns in primary care. First results from the multicare cohort study. BMC Health Serv Res 2012; 12:89.
Morin C, Joly P, Courville P, et al. Chronic eczematiform eruption in the elderly. Ann dermatol Venereol 2002; 129: 19–22.
Joly P, Benoit-Corven C, Baricault S, et al. Chronic eczematous eruptions in the elderly are associated with chronic exposure to calcium channel blockers. J Invest Dermatol 2007; 127: 2766–71.
Yoo J, Jue MS. Intractable pruritus with chronic eczema in an elderly patient caused by long-term intake of calcium channel blocker. Contact Dermatitis 2017; 77: 325–51.
Summers E, Bingham CB, Dahle KW, Sweeney C, Yong J, Sontheimer RD. Chronic eczematous eruptions in the aging. Further Support for an association with exposure to calcium channel blockers. JAMA Dermatol 2013; 149: 814–8.
Vena GA, Cassano N, Coco V, De Simone C. Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. Immunopharmacol Immunotoxicol 2013; 35: 447–50.
Krasovec M, Elsner P, Burg G. Generalized eczematous skin rash possibly due to HMG-CoA Reductase inhibitors. Dermatology 1993; 186: 248–52.
Al Saif F, Tétart F, Massy N, Joly P. Toxidermies eczématiformes au clopidogrel: à propos de quatre cas. Ann Dermatol Venereol 2012; 139: B292–3.
Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000; 25:522–9.
Richard MA, Corgibet F, Beylot-Barry M, et al. Sex-and age-ajusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study. JEADV 2018; 32: 1967–71.
Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy 2018; 73: 1284–93.
Bieber T, Bussman C. Atopic dermatitis. In: Dermatology, Vol 1, 3rd Ed. Bolognia JL, Jorizzo JL, Schaffer JV. Amsterdam: Elsevier, 2012; 203–17.
Tanei R, Hasegawa Y. Atopic dermatitis in older adults: a viewpoint from geriatric dermatology. Geriatr Gerontol Ibt 2016; 16:75–86.
Tanei R. Clinical characteristics, treatments, and prognosis of atopic eczema in the elderly. J Clin Med 2015; 4: 979–97.
Shabeen M, Silverberg JI. Atopic dermatitis is associated with osteoporosis and osteopenia in older adults. J Am Acad Dermatol 2019; 80:550–1.
Tanei R. Atopic dermatitis in older adults: a review of treatment options. Drugs Aging 2020; 37: 149–60.
Schnass W, Hüls A, Vierkötter A, et al. Traffic-related air pollution and eczema in the elderly: findings from the SALIA cohort. Int J Hyg Envron Health 2018;221:86 1–7.
Hüls A, Abramson MJ, Sugiri D, et al. Non atopic eczema in elderly women: effect of air pollution and genes. J Allergy Clin Immunol 2019; 143:378–85.
Tetart F, Joly P. Low doses of methotrexate for the treatment of chronic eczema in the elderly. J Eur Acad Dermatol Venereol 2011;25:1364–5.
Abrouk M, Farahnik B, Zhu TH, et al. Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses. J Am Acad Dermatol 2017; 77:177–9.
Brummer GC, Wang LT, Sontheimer RD. A possible role for dupilumab (Dupixent) in the management of idiopathic chronic eczematous eruption of aging. Dermatol Online J 2018; 24: 3.
Financial support: none. Conflicts of interest: none.
About this article
Cite this article
Tétart, F., Joly, P. Eczema in elderly people. Eur J Dermatol 30, 663–667 (2020). https://doi.org/10.1684/ejd.2020.3915
- atopic dermatitis
- drug hypersensitivity
- skin aging